General Surgery Devices Market Worth $26.5 Billion By 2026

The global general surgery devices market size is expected to reach USD 26.5 billion by 2026 registering a CAGR of 8.5%, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures being performed coupled with technological advancements is anticipated to drive the market. Moreover, rising awareness and patient affordability for plastic or reconstructive surgeries would propel the number of procedures conducted during the forecast period.

Global health initiatives for the advanced surgical procedure is expected to boost the market. In January 2017, Ethiopia Federal Ministry of Health (FMOH) launched the Health Sector Transformation Plan (HSTP) and Safe Surgery (SaLTS) program that prioritizes safe surgery and makes anesthesia care and emergency surgical services accessible and affordable.

Technological advancements are also contributing to the market growth. Several key companies are investing in R&D for the development of innovative products. For instance, development of medical robots to assist surgeons is a key advancement in the field. Medical robots offer several advantages, such as a 3D view of the operating field, reduced blood loss & transfusions, lower risk of infection, faster recovery time, minimal scarring, and high precision.

Furthermore, growing aging population and cases of road accidents and increased healthcare expenditure in emerging economies are likely to boost the market during the forecast period. According to the WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050 from 900 million in 2015. Geriatric population is more susceptible to a number of diseases, which is likely to increase the need for effective treatments, thereby driving the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market

Further key findings from the study suggest:

Disposable surgical supplies held the largest market share in 2018. Low product cost and regulatory support for the usage of disposable products is expected to fuel the demand for these devices
Asia Pacific is estimated to expand at the highest CAGR over the forecast period due to technological advancements, increasing investments and improving reimbursement scenario along with the growing medical tourism sector in the region
Medical robotics & computer-assisted surgery devices are projected to witness the maximum CAGR of 9.9% from 2019 to 2026 due to increasing R&D investments and availability of technologically advanced products
Some of the key companies in the market are Medtronic plc; Johnson & Johnson Services, Inc.; CONMED Corp.; Becton, Dickinson and Company (BD); B Braun Melsungen AG; Strykers; Boston Scientific Corp.; Erbe Elektromedizin GmbH; and The 3M Company

Surgical Stapling Devices Market Size Worth $8.02 Billion By 2026

The global surgical stapling devices market size is anticipated to reach USD 8.02 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.23% during the forecast period. Application of surgical staplers has gradually evolved from invasive surgeries to minimally invasive surgeries. With introduction of advanced surgical staplers, difficulties associated with the use of conventional staplers have been addressed.

Obesity is increasing among adults as well as adolescents below 18 years of age due to sedentary lifestyles and unhealthy diet patterns in this age group. In case of eating habits, people are more inclined towards fast food rather than healthy food. Growing busy schedule and increasing stress are both causing people to consume packed and processed food.

Severe cases of obesity cause other conditions, such as diabetes and cardiovascular conditions, resulting in many opting for bariatric surgery. According to the Canadian Institute for Health Information (CIHI) 2014 data, the number of bariatric surgeries has drastically increased from 1,600 in 2006-2007 to 6,000 in 2012-2013. This indicates high demand for these surgeries owing to increasing awareness about surgical options for weight loss.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-stapling-market

Further key findings from the report suggest:

Manual surgical stapling devices dominated the market in terms of revenue in 2018. However, powered devices are projected to witness strong growth during the forecast period
An alarming number of emergency cases can lead to surgical fatigue, thereby, reducing productivity. Powered stapling devices allow surgeons to perform more number of surgeries in emergency wards
There is an increasing demand for disposable devices due to heightened concerns for communicable infections. Owing to which, disposable staplers are likely to dominate the market through 2025
Disposable staples are made of plastic, whereas reusable staples are made of stainless steel. Both disposable and reusable staples have disposable cartridges and although reusable, staplers generate lesser surgical waste
North America dominated the overall market in terms of revenue in 2018. The growth of the region can be attributed to surging bariatric surgeries, introduction of powered staples, and soaring need for tissue and wound management
Key industry contributors include Covidien plc; Ethicon Endo-Surgery, Inc.; Intuitive Surgical, Inc.; United States Surgical Corp; Cardica, Inc.; Zimmer Holdings, Inc.; Stryker Corporation; Smith & Nephew plc; Conmed Corporation; and CareFusion Corporation
In November 2018, Ethicon launched ECHELON FLEX GST System for exceptional staple line integrity across wide range of tissue thickness under its Bariatric Revision Surgical Solutions.

Auto-injectors Market Size Worth $3.2 Billion by 2026

The global auto-injectors market size is expected to reach USD 3.18 billion by 2026, according to a new report by Grand View Research, Inc, exhibiting a CAGR of 19.5%. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth.

Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions.

In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.

Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and user-friendly. This is encouraging patients to adopt this technology for chronic illnesses.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/auto-injectors-market

Further key findings from the study suggest:

Disposable auto-injectors emerged as the largest segment owing to convenience and ease of use
Homecare settings accounted for largest share in end-use segment owing to increasing demand of products for daily administration of insulin
North America dominated the auto-injectors market with largest share in 2018. Increasing demand for new technologies along with advanced healthcare infrastructure is expected to boost market growth during the forecast period
Asia Pacific is expected to witness fastest growth during the forecast period owing to increasing number of diabetic patients
Some of the key players are Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Amgen; Owen Mumford; Ypsomed; Teva Pharmaceutical; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi

Oral Syringes Market Size Worth $868.6 Million By 2027

The global oral syringes market size is expected to reach USD 868.6 million by 2027, expanding at a CAGR of 4.2%, according to a new report by Grand View Research, Inc. The ability to deliver an accurate amount of medication, increase in the pediatric and geriatric surgeries, and the easy usability of the oral syringes are expected to propel market growth over the forecast period. In addition, recent development in the design and increase in the demand are expected to contribute to market growth.

Medication errors in the pediatric population are also expected to drive the market. According to the article published in the U.S. Pharmacist in 2019, approximately 200,000 medication errors are reported to the U.S. poison control centers every year and about 30.0% of cases are related to children. Unlike most drugs for adults, children’s medications are often liquid and administration of liquid medication by cups and spoons leads to serious errors. To reduce the incidence of medication errors in children, most of the healthcare agencies are promoting the use of the dispensers worldwide. For instance, the Institute for Safe Use of Medications (ISMP) publishes periodical newsletters and educational programs to increase the awareness regarding the dispenser in Spain.

In addition, rise in the birth rate across the world, minimum regulation for the consumable devices, and easy usability of the dispenser are expected to drive the market over the forecast period. Furthermore, benefits such as high reliability and dose accuracy over cups or droppers are increasing demand for the dispensers in the industry. According to survey conducted by the National Center for Biotechnology Information, most of the children’s hospitals and residency hospitals use oral syringes in U.S.

North America accounted for the highest market share in 2019 owing to advanced healthcare system and growing prevalence of chronic diseases in the country. In addition, the presence of major players in the region contributed to market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/oral-syringes-market

Further key findings from the study suggest:

By type, the clear oral syringes segment held the largest market share in 2019 owing to the low price in the industry
Reusable oral syringes held the largest market share of 51.0% in 2019 owing to their affordability and ability to pre-sterilize
The hospital segment held the largest market share due to the increase in the number of hospitalization throughout the world
Asia Pacific is expected to witness the fastest growth rate over the forecast period owing to a large number of pediatric population and increase in the awareness in the region.

Anastomosis Devices Market Size Worth $24.84 Million By 2025

The global anastomosis devices market size is projected to reach USD 24.84 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.2% during the forecast period. Rising prevalence of cardiovascular and gastrointestinal diseases is poised to propel the demand for anastomosis devices in the coming years.

According to WHO, 17.7 million people died from CVD in 2015, which represented 31.0% of all deaths in the world. It also states that 80% of these deaths are due to strokes and heart attacks. CHD/CAD (Coronary Heart/Artery Disease) is the most common type of heart disease and around 370,000 people die annually in the U.S. Surgery is crucial for the treatment of such life-threatening diseases, thereby increasing the adoption of anastomosis devices in these surgeries.

Lifestyle associated changes, medical procedures, and/or drug therapy can be effectively used to prevent or treat CAD in most people. Clearly, invasive cardiac surgery is not the first-line of treatment for patients, where less invasive options such as angioplasty and stenting are feasible. Nevertheless, for many patients with advanced or diffuse diseases, surgery remains the best option and anastomosis devices are widely used in such surgeries. Swelling demand for CABG, increasing geriatric population, reduced risk associated with surgery, and growing number of people who need re-operations after 10 to 12 years from their first bypass surgery.

Introduction of technologically advanced products with associated advantages such as less exposure to anesthesia, reduced operating time, reduced chances of blood leaks, and convenience are among factors likely to stoke growth of the market. Moreover, presence of favorable reimbursement structure in developed countries is estimated to bolster the growth of the market. For instance, Medicare policies in the U.S. offer reimbursement for CABG and colorectal surgery.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/anastomosis-devices-market

Further key findings from the report suggest:

Disposable anastomotic devices will continue to dominate the market until 2025, commanding just over 88.0% of the overall market. The growth of the segment can be attributed to wide product offering of various market players
Reusable anastomotic devices are anticipated to exhibit a CAGR of about 6.0% over the forecast period owing to increasing need to reduce biomedical waste
On the basis of application, cardiovascular surgery held the largest share of the market in 2016 owing to rising prevalence of CHD and increasing number of CABG procedures around the globe
North America was at the forefront in the global arena owing to the presence of well-structured reimbursement policies, widening base of target population, and local presence of a large number of key players
Asia Pacific is expected to grow at a lucrative rate of 6.1% during the forecast period owing to growing geriatric population, rising incidence of CVD, rapid developments in the healthcare sector, and increasing disposable income
Key market players are engaged in various strategies such as distribution agreements to augment their market penetration. For instance, in February 2016, Maquet Medical Systems USA entered into a distribution agreement with BIOTRONIK to distribute the latter’s peripheral vascular devices in the U.S.

Endoscopic Vessel Harvesting Systems Market Worth $3.4 Billion By 2025

The global endoscopic vessel harvesting systems market is expected to reach USD 3.4 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of the patient population toward minimally invasive cardiac surgeries is one of the key factors expected to drive the market in the coming few years.

The introduction of endoscopic vessel harvesting technology in the field of cardiac surgery was a significant milestone in 1996. According to estimates by the Texas Heart Institute, every year over 200,000 procedures were performed in the U.S. Also, based on the statistics published by the department of surgery (Washington University School of Medicine in St. Louis), they perform Coronary Artery Bypass Grafting (CABG) surgeries on approximately 0.5 million people every year. The growing demand for these procedures and technologically advanced surgical procedures are among the few factors anticipated to boost the market over the forecast period.

The presence of favorable reimbursement policies in the U.S. pertaining to CABG surgeries is anticipated to increase the number of these surgeries. In July 2016, the Department of Health & Human Services announced that it will begin implementing bundled payment models for high-quality, coordinated cardiac and hip fracture care. The market is highly concentrated with a limited number of products and market players operating in this space. Many studies stated that the open vessel harvesting technique is as effective as a minimally invasive vessel harvesting technique. However, the growing awareness regarding benefits of Endoscopic Vessels Harvesting (EVH), such as minimally invasive nature, fewer complications, and quick recuperation are some of the factors that are anticipated to propel its growth during the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/endoscopic-vessel-harvesting-system-market

Further key findings from the report suggest:

The global endoscopic vessel harvesting system market size was estimated at USD 1,881.7 million in 2016 and is expected to grow at a CAGR of 6.1% from 2017 to 2025
Reusable EVH systems emerged as the largest product segment in 2015 and is estimated to generate revenue of over USD 2,136.0 million by 2025
Global disposable EVH systems was USD 639.3 million in 2016 and is anticipated to witness the fastest growth over the next 8 years
The industry in the Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. The regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
Some of the key players including MAQUET Holding B.V. & Co. KG; CARDIO MEDICAL GmbH; Terumo Cardiovascular Group; Med Europe S.r.l. (Elite Life Care); LivaNova plc. (Sorin and Cyberonics); and Saphena Medical, Inc. dominated the global endoscopic vessels harvesting systems market.

Flexible, Printed & Thin Film Battery Market Worth $67.1 Billion By 2025

The global flexible, printed and thin film battery market size is expected to reach USD 67.1 billion by 2025, accelerating at a CAGR of 39.7% over the forecast period, according to a new report by Grand View Research, Inc. Rising adoption of wearable devices including watches, smart glasses, and fitness trackers is likely to strengthen the growing demand for flexible, printed and thin film battery over the forecast period.

The market is primarily driven by increasing demand for small, flexible, thin, and low-weight devices with higher lifetime and efficient micro energy storage capacity. Growing adoption of such printed, flexible battery in medical applications, consumer electronics, smart cards, and sensors is further expected to complement the growth of the industry. Furthermore, advancements in wearable sensor technology, IoT innovation trends, and mobile cloud computing are expected to positively impact market growth over the forecast period.

Most wearable applications such as smart devices and smart fabrics require flexible, ultra-thin, durable battery, which, in turn, is boosting the product demand. Smart cards application segment accounts for a significant share of the market. Transaction security, logistics, material management, access control, and inventory tracking are the key application areas of smart cards. Flexible, printed and thin film batteries are extensively used in several medical applications including printed batteries for transdermal skin patches and micro-power thin film batteries for disposable healthcare devices. The penetration of thin film, lightweight batteries in medical devices is estimated to register a significant growth rate due to the increasing demand for portable medical equipment.

Industry participants are focusing on advanced manufacturing techniques to increase product penetration in the market. For instance, Europe-based Imec manufactures a 3D thin-film battery constructed over a structured substrate instead of a planar substrate to provide enhanced energy density and usage of low ionic conductivity electrolyte materials. This technique is expected to aid in lowering the per-unit cost of flexible, printed and thin film batteries, which may otherwise hinder the market growth.

Collaborations between electronic manufacturers & battery manufacturers are likely to fuel the growth of consumer electronics segment. Declining cost of rechargeable batteries is expected to further drive the market growth in low-power applications such as smart cards RF-ID tags. In Asia Pacific, China occupies the largest share in printed, thin film batteries market owing to rising adoption of IoT along with the growing demand for portable electronic devices.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/flexible-printed-thin-film-battery-market

Further key findings from the report suggest:

Wearable devices segment grabbed the largest revenue share of the market and was valued at USD 2.0 billion in 2018 owing to the rapid advancements in wearable technology
Consumer electronics is likely to be the fastest-growing segment, escalating at a CAGR of 39.6% over the forecast period owing to large consumer base for electronic industry globally
Rechargeable segment is anticipated to attain significant value of USD 32.3 billion by 2025 owing to increased use of rechargeable batteries in portable consumer electronic devices
The flexible, printed and thin film battery market in Asia Pacific was valued at USD 2.0 billion in 2018 and is likely to witness substantial growth rate owing to an increase in manufacturing of electronics in emerging countries
Enfucell, BrightVolt, STMicroelectronics, Cymbet, Blue Spark Technologies, Imprint Energy, Printed Energy Pty Ltd., Jenax Inc, Ilika, and Excellatron are some of the significant participants of printed, flexible, thin film battery industry.

Anti-pollution Mask Market Size Worth $22.3 Billion By 2027

The global anti-pollution mask market size is expected to reach USD 22.3 billion by 2027, expanding at a CAGR of 30.1% over the forecast period, according to a new report by Grand View Research, Inc. Factors such as rising awareness for remedial measures to combat increased pollution levels and high rate of adoption of healthy lifestyle are expected to remain the prominent trends in the market.

The recent outbreak of COVID-19 pandemic is expected to drive the demand for anti-pollution masks during the forecast period. According to a report by Cable News Network, 3M Company has been witnessing an unprecedented spike in the demand for N95 respirator masks since the beginning of 2020 across the globe. Shortage of protection masks in maximum offline stores as well as major e-commerce platforms has led to manufacturers ramping up their production capacity and distribution channels, which is one of the key attributes driving the market growth.

The growing urbanization and industrialization particularly in developing regions such as India and China plays a predominant role in increasing the pollution level. In addition, increasing number of vehicles adds to further degradation of air quality. These factors play a major role in driving the demand for anti-pollution masks in the market. Anti-pollution masks are available in different standard ratings such as N95, N99, N100, P95, and P100, as recommended by NIOSH, an association of U.S. Centers for Disease Control and Prevention.

The P rated masks are resistant to oil based particles and are used for working at places exposed to oil whereas, N rated ones are not resistant to oil based pollutants. N95 filters up to 95% of the Particulate Matter 2.5 (PM2.5) while, N99 masks filter up to 99% of PM2.5 owing to the higher rate of filtration.

Asia Pacific region is expected to witness the largest as well as fastest growth owing to rapid industrialization and development in automobile sector. The rapidly growing population in developing economies such as India and China is leading to rapid urbanization, which is increasing the pollutant levels in the atmosphere, thus boosting the product demand. According to a report by Institute for Health Metrics and Evaluation, 5.5 people die every year on account of indoor and outdoor air pollution.

The prominent players in the anti-pollution mask market are focusing on product innovation. For instance, in November 2016, Xiaomi launched battery powered anti-pollution mask to filter out PM2.5 particles from breathing. It is manufactured with hand-woven polyester material and equipped with battery powered nano filter, which is chargeable through a USB port. Furthermore, in November 2018, O2TODAY launched urban face mask, O2SafeAir through global travel retail Indiegogo. It is expected to be highly breathable, machine washable and engages with interchangeable filters from protection against pollution and microorganisms.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/anti-pollution-mask-market

Further key findings from the report suggest:

The recent outbreak of COVID-19 pandemic is expected to drive the demand for anti-pollution masks. Consumers have been gravitating toward the usage of anti-pollution masks to protect themselves from breathing in the pathogens that may be present in the air
In terms of revenue, the reusable product segment is projected to ascend at a CAGR of 30.2% from 2020 to 2027
Offline channel of distribution dominated the global anti-pollution mask market with an overall revenue share of over 64% in 2019
North America is expected to remain one of the key markets, accounting for 28.7% of global revenue share in 2019
Increasing rate of pollution level owing to rapid industrialization and urbanization in countries such as India and China, is expected to boost the growth of Asia Pacific market
The industry is highly competitive in nature with the main players including 3M, Honeywell International Inc.; KCWW; Totobobo Pte. Ltd.; MSA; and RESPRO.